CONTEXTE: Il existe très peu de données directes sur l'administration de corticostéroïdes
aux patients atteints de la maladie à coronavirus 2019 (COVID-19). Les données indirectes …

BACKGROUND: Very little direct evidence exists on use of corticosteroids in patients with
coronavirus disease 2019 (COVID-19). Indirect evidence from related conditions must …

Abstract The World Health Organization (WHO) has published guidance recommending
systemic corticosteroids for the treatment of patients with severe or critical COVID-19 and no …

Background: In the current SARS-CoV-2 pandemic, there has been worldwide debate on the
use of corticosteroids in COVID-19. In a recent RCT (RECOVERY trial), a reduced 28-day …

Background To assess the efficacy and safety of corticosteroids in COVID-19 patients
compared with standard care or placebo. Methods Electronic databases were searched to …

Background Since its appearance in late 2019, infections caused by severe acute
respiratory syndrome coronavirus 2 have created unprecedented challenges for health …

Objective: To review available evidence on corticosteroids in acute respiratory distress
syndrome (ARDS), Coronavirus Disease 2019 (COVID-19), and other viral pneumonias …

Due to a lack of definitive treatment, many drugs were repurposed for Coronavirus disease
(COVID-19) treatment; among them, corticosteroid is one. However, its benefit or harm while …

The current evidence suggests that the rapid clinical progression of the Coronavirus
Disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome …

Objectives Coronavirus disease 2019 (COVID-19) remains a global challenge.
Corticosteroids constitute a group of anti-inflammatory and immunosuppressive drugs that …